Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Roles for the Trypanosoma brucei P2 Transporter in DB75 Uptake and Resistance

Charlotte A. Lanteri, Mhairi L. Stewart, Janice M. Brock, Vincent P. Alibu, Steven R. Meshnick, Richard R. Tidwell and Michael P. Barrett
Molecular Pharmacology November 2006, 70 (5) 1585-1592; DOI: https://doi.org/10.1124/mol.106.024653
Charlotte A. Lanteri
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mhairi L. Stewart
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janice M. Brock
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vincent P. Alibu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven R. Meshnick
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard R. Tidwell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael P. Barrett
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

A novel trypanocide, 2,5-bis(4-amidinophenyl)furan (DB75), in its prodrug amidoxime-derivative form, 2,5-bis(4-amidinophenyl)furan-bis-O-methylamidoxime (DB289), is in trials as the first orally administered drug for human African trypanosomiasis. DB75 is a diamidine. Resistance to some diamidines correlates to loss of uptake via the P2 aminopurine transporter. We show here that uptake of DB75 into Trypanosoma brucei also occurs principally via the P2 transporter. Uptake of tritiated DB75 occurred via a high-affinity (Km app, 3.2 μM) carriermediated route that was inhibited by adenosine, adenine, and pentamidine, all known substrates of the P2 transporter. Trypanosomes lacking the TbAT1 gene that encodes the P2 transporter demonstrated an 11-fold reduction in sensitivity to DB75 when measured under controlled in vitro conditions. These knockout cells were also less sensitive to DB75 than wild-type cells in mice. Initial uptake rates of DB75 into the Δtbat1 knockout cell line were greatly reduced compared with rates in wild-type cells. A trypanosome cell line selected in vitro for DB75 resistance was shown to have lost P2-mediated DB75 uptake. The TbAT1 gene was mapped to chromosome V of the T. brucei genome and the DB75-resistant parasites were shown to have deleted both alleles of this gene. Fluorescence microscopy of DB75-treated trypanosomes revealed that DB75 fluorescence localizes rapidly within the DNA-containing organelles of wild-type trypanosomes, whereas no fluorescence was observed in Δtbat1-null parasites or in the parasites selected for resistance to DB75.

Footnotes

  • This work was funded by the Bill and Melinda Gates Foundation. C.A.L. and M.L.S. contributed equally to this work

  • ABBREVIATIONS: HAT, human African trypanosomiasis; DB75, 2,5-bis(4-amidinophenyl)furan; DB289, 2,5-bis(4-amidinophenyl)furan-bis-O-methylamidoxime; DB75R-CL1, the T. brucei strain selected for resistance to DB75; DAPI, 4′,6-diamidino-2-phenylindole dihydrochloride; melarsoprol, 2-[4-[(4,6-diamino-1,3,5-triazin-2-yl)amino]phenyl]-1,3,2-dithiarsolan-4-yl]methanol; pentamidine, 4-[5-(4-carbamimidoylphenoxy-)pentoxy]benzenecarboximidamide; suramin, 8-[[4-methyl-3-[[3-[[3-[[2-methyl-5-[(4,6,8-trisulfonaphthalen-1-yl) carbamoyl]phenyl]carbamoyl]phenyl]carbamoylamino]benzoyl]amino]benzoyl]amino]naphthalene-1,3,5-trisulfonic acid; eflornithine, 2,5-diamino-2-(difluoromethyl)pentanoic acid; diminazene, 4-[2-(4-carbamimidoylphenyl)iminohydrazinyl]benzenecarboximidamide; PCR, polymerase chain reaction.

  • ↵ Embedded Image The online version of this article (available at http://molpharm.aspetjournals.org) contains supplemental material.

  • ↵1 Current affiliation: Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland.

  • ↵2 Current affiliation: Zentrum für Molekulare Biologie Heidelberg, Heidelberg, Germany.

    • Received March 27, 2006.
    • Accepted August 15, 2006.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 70 (5)
Molecular Pharmacology
Vol. 70, Issue 5
1 Nov 2006
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Roles for the Trypanosoma brucei P2 Transporter in DB75 Uptake and Resistance
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Roles for the Trypanosoma brucei P2 Transporter in DB75 Uptake and Resistance

Charlotte A. Lanteri, Mhairi L. Stewart, Janice M. Brock, Vincent P. Alibu, Steven R. Meshnick, Richard R. Tidwell and Michael P. Barrett
Molecular Pharmacology November 1, 2006, 70 (5) 1585-1592; DOI: https://doi.org/10.1124/mol.106.024653

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

Roles for the Trypanosoma brucei P2 Transporter in DB75 Uptake and Resistance

Charlotte A. Lanteri, Mhairi L. Stewart, Janice M. Brock, Vincent P. Alibu, Steven R. Meshnick, Richard R. Tidwell and Michael P. Barrett
Molecular Pharmacology November 1, 2006, 70 (5) 1585-1592; DOI: https://doi.org/10.1124/mol.106.024653
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • CTS bias
  • Nelfinavir and PXR
  • P2X7 Positive Modulator Structure-Activity Relationship
Show more Articles

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics